Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results
- Resource Type
- Article
- Source
- In
Journal of Clinical Epidemiology April 2022 144:43-55 - Subject
- Language
- ISSN
- 0895-4356